🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
154.68
-1.91 (-1.22%)
Nov 20, 2026, 10:20 AM EST - Market open

Neurocrine Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,65614,14113,82012,94611,4828,080
Market Cap Growth
13.27%2.32%6.75%12.75%42.11%-9.78%
Enterprise Value
15,37013,50612,87812,12410,9667,766
Last Close Price
156.59141.83136.50131.76119.4485.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
22.9729.5540.4951.8574.3290.18
Forward PE
12.9915.8718.1521.3422.5324.55
PS Ratio
4.284.945.876.867.717.13
PB Ratio
4.094.355.345.806.725.88
P/TBV Ratio
13.354.355.345.916.905.88
P/FCF Ratio
15.2418.8924.8035.8035.5634.66
P/OCF Ratio
14.8718.0723.2133.2033.8331.50
PEG Ratio
0.330.750.310.650.661.12

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.204.725.476.437.376.85
EV/EBITDA Ratio
14.5620.2620.6429.1441.4435.51
EV/EBIT Ratio
15.7921.2221.5730.7144.0437.38
EV/FCF Ratio
14.9718.0423.1133.5333.9633.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.120.140.180.190.150.32
Debt / EBITDA Ratio
0.400.650.680.990.941.88
Debt / FCF Ratio
0.440.630.821.190.811.89
Net Debt / Equity Ratio
-0.07-0.31-0.24-0.27-0.42-0.20
Net Debt / EBITDA Ratio
-0.27-1.51-0.99-1.45-2.74-1.24
Net Debt / FCF Ratio
-0.28-1.35-1.11-1.67-2.25-1.16
Asset Turnover
0.750.690.680.670.670.60
Inventory Turnover
19.3216.9015.9916.4814.8511.71
Quick Ratio
1.722.923.062.252.493.65
Current Ratio
2.043.393.402.452.703.96
Return on Equity (ROE)
20.41%16.38%14.16%12.68%10.03%7.17%
Return on Assets (ROA)
12.45%9.53%10.71%8.78%7.01%6.82%
Return on Invested Capital (ROIC)
20.19%20.50%23.31%22.75%17.26%19.95%
Return on Capital Employed (ROCE)
21.20%16.40%18.60%15.20%13.60%11.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4.35%3.38%2.47%1.93%1.35%1.11%
FCF Yield
6.56%5.29%4.03%2.79%2.81%2.89%
Buyback Yield / Dilution
-1.98%1.16%-2.67%-2.12%-1.02%-0.10%
SEC Filings: 10-K · 10-Q